Medea Communications wins Orion Pharmaceuticals account

Medea Communications has been hired by Orion Pharmaceuticals to work on its pipeline product for sedation in intensive care, dexmedetomidine.

Medea MD: Kate Hawker
Medea MD: Kate Hawker

Medea was set up in September 2009 by former Fleishman-Hillard directors Kate Hawker and Charlotte Florence (PRWeek, 9 September 2009).

The programme for Orion leads on a major advocacy development programme across more than 20 markets in Europe to prepare the market for a 2011 launch.

Orion Pharma is the research and development-oriented pharmaceutical division of Orion Corporation, a Finnish listed company that develops, manufactures and markets pharmaceuticals.




Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in